Endogenous Dimethyltryptamine Reconsidered: A Constraint-Based Trace Amine Ensemble Model

Endogenous dimethyltryptamine (DMT) has been detected intermittently in mammalian systems, yet its physiological relevance remains unresolved due to low steady-state concentrations, rapid monoamine oxidase-mediated clearance, and inconsistent detection across tissues. This position paper argues that the prevailing single-molecule, tonic-neurotransmitter framing of endogenous DMT is misaligned with its metabolic biology. We propose that DMT functions as a transient component of a constraint-governed trace amine ensemble composed of indole- and phenyl-derived amines whose biological impact emerges from coordinated flux rather than sustained extracellular concentration. Within this framework, ensemble configuration is determined by precursor partitioning, enzymatic gating, clearance dominance, and physicochemical membrane permeability. Central glial networks regulate volume transmission and degradation kinetics, while neuron-glia microdomains in the brain and high-surface-area neuroendocrine interfaces in the lung and gut are proposed as conditional relay architectures for localized indole methylation. The absence of the 5-hydroxyl group enables non-hydroxylated ensemble members to traverse lipid barriers that restrict canonical monoamines, linking peripheral metabolic shifts to central neural states. Inflammatory activation amplifies constraint through coordinated tryptophan diversion into the kynurenine pathway, increased monoamine oxidase expression, and expansion of peripheral hydroxylation flux, collectively compressing ensemble amplitude and duration. This model reframes endogenous DMT not as a missing classical neurotransmitter, but as a pulse dependent state modulatory component within a distributed metabolic architecture. The framework generates experimentally falsifiable predictions concerning spatial enzyme adjacency, flux coupling, inflammatory compression, and transient pulse detection, providing a structured basis for future investigation. To aid interpretation of this systems-level framework, schematic figures are provided summarizing the proposed peripheral relay architectures, central neuron-glia relay model, and constraint logic governing ensemble-state transitions.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-08-25
DOI
https://doi.org/10.5281/zenodo.21411350
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Endogenous Dimethyltryptamine Reconsidered: A Constraint-Based Trace Amine Ensemble Model

Lester H. LaCombe II
Zenodo (CERN European Organization for Nuclear Research)
Psychedelics and Drug Studies
article

Endogenous Dimethyltryptamine Reconsidered: A Constraint-Based Trace Amine Ensemble Model

Lester H. LaCombe II
article en

Abstract

Endogenous dimethyltryptamine (DMT) has been detected intermittently in mammalian systems, yet its physiological relevance remains unresolved due to low steady-state concentrations, rapid monoamine oxidase-mediated clearance, and inconsistent detection across tissues. This position paper argues that the prevailing single-molecule, tonic-neurotransmitter framing of endogenous DMT is misaligned with its metabolic biology. We propose that DMT functions as a transient component of a constraint-governed trace amine ensemble composed of indole- and phenyl-derived amines whose biological impact emerges from coordinated flux rather than sustained extracellular concentration. Within this framework, ensemble configuration is determined by precursor partitioning, enzymatic gating, clearance dominance, and physicochemical membrane permeability. Central glial networks regulate volume transmission and degradation kinetics, while neuron-glia microdomains in the brain and high-surface-area neuroendocrine interfaces in the lung and gut are proposed as conditional relay architectures for localized indole methylation. The absence of the 5-hydroxyl group enables non-hydroxylated ensemble members to traverse lipid barriers that restrict canonical monoamines, linking peripheral metabolic shifts to central neural states. Inflammatory activation amplifies constraint through coordinated tryptophan diversion into the kynurenine pathway, increased monoamine oxidase expression, and expansion of peripheral hydroxylation flux, collectively compressing ensemble amplitude and duration. This model reframes endogenous DMT not as a missing classical neurotransmitter, but as a pulse dependent state modulatory component within a distributed metabolic architecture. The framework generates experimentally falsifiable predictions concerning spatial enzyme adjacency, flux coupling, inflammatory compression, and transient pulse detection, providing a structured basis for future investigation. To aid interpretation of this systems-level framework, schematic figures are provided summarizing the proposed peripheral relay architectures, central neuron-glia relay model, and constraint logic governing ensemble-state transitions.

Zenodo (CERN European Organization for Nuclear Research)
Highland Community College - Kansas (US)
Openalex Percentile: Top 6%
Psychedelics and Drug Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.